From: CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer
No. of cases | PFS | OS | ||||
---|---|---|---|---|---|---|
Median (95% CI) | P value* | Median (95% CI) | P value* | |||
All patients | Decreases ≥20% | 105 | 4.04 (2.80–5.28) | 0.002 | 7.62 (5.83–9.41) | 0.002 |
Non-decrease & decreases< 20% | 95 | 6.57 (5.43–7.71) | 10.68 (9.33–12.03) | |||
Baseline platelet level | ||||||
Tertile 1 (lowest) | Decreases ≥20% | 38 | 2.46 (0.29–4.64) | < 0.001 | 5.68 (4.60–6.77) | 0.003 |
(100–166) × 109/L | Non-decrease & decreases< 20% | 28 | 7.75 (6.11–9.40) | 10.61 (8.97–12.26) | ||
Tertile 2 | Decreases ≥20% | 31 | 3.98 (2.48–5.47) | 0.48 | 6.47 (3.39–9.56) | 0.07 |
(167–220) × 109/L | Non-decrease & decreases< 20% | 36 | 4.67 (3.77–5.56) | 10.48 (7.59–13.37) | ||
Tertile 3 (highest) | Decreases ≥20% | 36 | 5.55 (4.82–6.29) | 0.34 | 9.36 (8.21–10.51) | 0.50 |
(221–558) × 109/L | Non-decrease & decreases< 20% | 31 | 7.03 (5.37–8.69) | 11.04 (7.45–14.63) |